Cargando…
Advancing pharmaceuticals and patient safety in Saudi Arabia: A 2030 vision initiative
Low-quality medicines deliver sub-optimal clinical outcomes and waste precious health resources. It is important to ensure that public funds are spent on healthcare technologies that meet national regulatory bodies such as the Saudi Food and Drug Authority (SFDA), quality standards for safety, effic...
Autores principales: | Alhawassi, Tariq M., Abuelizz, Hatem A., Almetwazi, Mansour, Mahmoud, Mansour A., Alghamdi, Ahmed, Alruthia, Yazed S., BinDhim, Nasser, Alburikan, Khalid A., Asiri, Yousif A., Pitts, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783811/ https://www.ncbi.nlm.nih.gov/pubmed/29379335 http://dx.doi.org/10.1016/j.jsps.2017.10.011 |
Ejemplares similares
-
The status of licensed pharmacy workforce in Saudi Arabia: a 2030 economic vision perspective
por: AlRuthia, Yazed, et al.
Publicado: (2018) -
The association of vitamin D deficiency and glucose control among diabetic patients
por: Almetwazi, Mansour S, et al.
Publicado: (2017) -
Factors associated with glycemic control in type 2 diabetic patients in Saudi Arabia
por: Almetwazi, Mansour, et al.
Publicado: (2019) -
Oral antidiabetic medication adherence and glycaemic control among patients with type 2 diabetes mellitus: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia
por: Balkhi, Bander, et al.
Publicado: (2019) -
Pharmacy students’ satisfaction with Introductory Pharmacy Practice Experiences (IPPE) at community pharmacy: The case of Saudi Arabia
por: Almetwazi, Mansour, et al.
Publicado: (2020)